Skip to page navigation menu Skip entire header
Brown University
Skip 13 subheader links

Epigenetics, Neurobehavior, and Toxic Stress in Children with Prenatal Methamphetamine Exposure

Description

Abstract:
Objective: To assess the association between prenatal methamphetamine exposure (PME) and methylation of the gene 11-Beta hydroxysteroid dehydrogenase type 2 (11B-HSD2) Methods: The Infant Development, Environment, and Lifestyle Study (IDEAL), a prospective, longitudinal study of PME and child outcomes enrolled postpartum mother-infant dyads in California, Hawaii, Iowa, and Oklahoma. Prenatal exposure was defined by maternal self-report and/or meconium toxicology screening. Exposed and comparison groups were matched on race, birth weight, health insurance, and education in the original study. In this study at ages 10-11 years, 100 dyads from California and Hawaii were assessed for drug exposure and methylation of the gene 11B-HSD2. Hierarchical linear models were used to determine the association between PME and methylation of 11B-HSD2 with adjustment for early childhood adversity and cortisone level. Results: Methamphetamine (MA) exposure and early childhood adversity were statistically significant predictors of methylation of 11B-HSD2 at the CpG2 site. Conclusion: This is the first evidence of MA exposure as a stressor on child neurobehavior, which confirms the third pathophysiology of MA, and the first report of the epigenetic stress model in the context of MA use.
Notes:
Thesis (M. P. H.)--Brown University, 2017

Access Conditions

Rights
In Copyright
Restrictions on Use
Collection is open for research.

Citation

Oni-Orisan, Oluwadamilola, "Epigenetics, Neurobehavior, and Toxic Stress in Children with Prenatal Methamphetamine Exposure" (2017). Public Health Theses and Dissertations. Brown Digital Repository. Brown University Library. https://doi.org/10.7301/Z08S4NCS

Relations

Collection: